Verano Provides Update on the Canadian Postal Strike, the Company's Special Meeting Materials and Voting Instructions GlobeNewswire October 06, 2025 CHICAGO, Oct. 06, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, is advising shareholders that due to the ongoing Canadian postal strike, […]

Mobilicom to Unveil Comprehensive New Cybersecurity Solution for Drones and Robotics at the Association of the U.S. Army (AUSA) 2025 Annual Meeting & Exposition in Washington D.C. GlobeNewswire October 06, 2025 Mobilicom will conduct live demonstrations of its military grade, field proven end-to-end solutions, including its OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking,

Mobix Labs Moves Decisively with All-Cash $1.30 Per Share Offer for Peraso — a 53% Premium That Signals New Phase of Growth 53% Premium All-Cash Offer Highlights Mobix Labs' Momentum and Growth Vision GlobeNewswire October 06, 2025 IRVINE, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (Nasdaq: MOBX), a provider of advanced connectivity

Strive Appoints Ben Werkman as Chief Investment Officer to Advance Bitcoin Strategy GlobeNewswire October 06, 2025 DALLAS, Oct. 06, 2025 (GLOBE NEWSWIRE) — Strive, Inc. (“Strive” or the “Company”) (Nasdaq: ASST) today announced the appointment of Ben Werkman as Chief Investment Officer (“CIO”) reporting to Strive Chairman and Chief Executive Officer (“CEO”) Matt Cole. A

Skye Bioscience Reports Topline CBeyond(TM) Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial GlobeNewswire October 06, 2025 Nimacimab monotherapy did not meet its primary endpoint for weight loss; preliminary pharmacokinetic analysis showed lower than expected drug exposure, potentially indicating the need for higher dosing as a monotherapy. Clinically meaningful additional weight loss observed

Apollo Silver Meets Top County Leaders at San Bernardino County Forum Highlights Ongoing Support for Responsible Mining Development GlobeNewswire October 06, 2025 VANCOUVER, British Columbia, Oct. 06, 2025 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo Silver” or the “Company“) (TSX.V:APGO, OTCQB:APGOD, Frankfurt:6ZF) is pleased to announce that it was invited to participate in an industry

ImprimisRx Announces Leadership Changes GlobeNewswire October 06, 2025 Frank Mullery Appointed Chief Executive Officer of ImprimisRx Bridseida Cruz Appointed Head of Quality of ImprimisRx NASHVILLE, Tenn., Oct. 06, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced leadership changes at its wholly-owned subsidiary, ImprimisRx.

Kaltura Announces CFO Departure GlobeNewswire October 06, 2025 NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) — Kaltura, Inc. (Nasdaq: KLTR, “Kaltura” or the “Company”), the Video Experience Cloud, today announced that John Doherty, Chief Financial Officer, will be stepping down effective December 5, 2025. Mr. Doherty informed the Company that he is taking on a

Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM) GlobeNewswire October 06, 2025 Following Scientific Advice and Guidance from Scientific Advice Working Party (SAWP) of EMA, Submission of CMA Application for Iopofosine I 131 as

Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives GlobeNewswire October 06, 2025 NEWTOWN, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) — Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory